Erratum: Epidermal Growth Factor Receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer (Clinical Cancer Research(2004)10(8594–602)Doi:10.1158/1078-0432.CCR-04-0690)

Bradley A. Schiff, Andrea B. McMurphy, Samar A. Jasser, Maher N. Youne, Dao Doan, Orhan G. Yigitbasi, Seungwon Kim, Ge Zhou, Mahitosh Mandal, Benjamin N. Bekele, FChristopher C. Holsinger, Steven I. Sherman, Sai Ching Yeung, Adel K. El-Naggar, Jeffrey N. Myers

Research output: Contribution to journalComment/debate

Abstract

The editors are publishing this note to alert readers to a concern about this article (1): In Fig. 2B, a splice line is missing in the NPA 187 lane of the b-actin panel.

Original languageEnglish (US)
Number of pages1
JournalClinical Cancer Research
Volume25
Issue number15
DOIs
StatePublished - Aug 1 2019

Fingerprint

Epidermal Growth Factor Receptor
Actins
Growth
Research
Neoplasms
Anaplastic Thyroid Carcinoma
gefitinib

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Erratum : Epidermal Growth Factor Receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer (Clinical Cancer Research(2004)10(8594–602)Doi:10.1158/1078-0432.CCR-04-0690). / Schiff, Bradley A.; McMurphy, Andrea B.; Jasser, Samar A.; Youne, Maher N.; Doan, Dao; Yigitbasi, Orhan G.; Kim, Seungwon; Zhou, Ge; Mandal, Mahitosh; Bekele, Benjamin N.; Holsinger, FChristopher C.; Sherman, Steven I.; Yeung, Sai Ching; El-Naggar, Adel K.; Myers, Jeffrey N.

In: Clinical Cancer Research, Vol. 25, No. 15, 01.08.2019.

Research output: Contribution to journalComment/debate

Schiff, Bradley A. ; McMurphy, Andrea B. ; Jasser, Samar A. ; Youne, Maher N. ; Doan, Dao ; Yigitbasi, Orhan G. ; Kim, Seungwon ; Zhou, Ge ; Mandal, Mahitosh ; Bekele, Benjamin N. ; Holsinger, FChristopher C. ; Sherman, Steven I. ; Yeung, Sai Ching ; El-Naggar, Adel K. ; Myers, Jeffrey N. / Erratum : Epidermal Growth Factor Receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer (Clinical Cancer Research(2004)10(8594–602)Doi:10.1158/1078-0432.CCR-04-0690). In: Clinical Cancer Research. 2019 ; Vol. 25, No. 15.
@article{a93cb927d38a491c9cff9f3387006746,
title = "Erratum: Epidermal Growth Factor Receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer (Clinical Cancer Research(2004)10(8594–602)Doi:10.1158/1078-0432.CCR-04-0690)",
abstract = "The editors are publishing this note to alert readers to a concern about this article (1): In Fig. 2B, a splice line is missing in the NPA 187 lane of the b-actin panel.",
author = "Schiff, {Bradley A.} and McMurphy, {Andrea B.} and Jasser, {Samar A.} and Youne, {Maher N.} and Dao Doan and Yigitbasi, {Orhan G.} and Seungwon Kim and Ge Zhou and Mahitosh Mandal and Bekele, {Benjamin N.} and Holsinger, {FChristopher C.} and Sherman, {Steven I.} and Yeung, {Sai Ching} and El-Naggar, {Adel K.} and Myers, {Jeffrey N.}",
year = "2019",
month = "8",
day = "1",
doi = "10.1158/1078-0432.CCR-19-2052",
language = "English (US)",
volume = "25",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "15",

}

TY - JOUR

T1 - Erratum

T2 - Epidermal Growth Factor Receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer (Clinical Cancer Research(2004)10(8594–602)Doi:10.1158/1078-0432.CCR-04-0690)

AU - Schiff, Bradley A.

AU - McMurphy, Andrea B.

AU - Jasser, Samar A.

AU - Youne, Maher N.

AU - Doan, Dao

AU - Yigitbasi, Orhan G.

AU - Kim, Seungwon

AU - Zhou, Ge

AU - Mandal, Mahitosh

AU - Bekele, Benjamin N.

AU - Holsinger, FChristopher C.

AU - Sherman, Steven I.

AU - Yeung, Sai Ching

AU - El-Naggar, Adel K.

AU - Myers, Jeffrey N.

PY - 2019/8/1

Y1 - 2019/8/1

N2 - The editors are publishing this note to alert readers to a concern about this article (1): In Fig. 2B, a splice line is missing in the NPA 187 lane of the b-actin panel.

AB - The editors are publishing this note to alert readers to a concern about this article (1): In Fig. 2B, a splice line is missing in the NPA 187 lane of the b-actin panel.

UR - http://www.scopus.com/inward/record.url?scp=85070086452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070086452&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-19-2052

DO - 10.1158/1078-0432.CCR-19-2052

M3 - Comment/debate

C2 - 31371312

AN - SCOPUS:85070086452

VL - 25

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 15

ER -